IQVIA HOLDINGS INC. Share-based Payment Arrangement, Expense, Tax Benefit
IQVIA HOLDINGS INC. (IQV) reported Share-based Payment Arrangement, Expense, Tax Benefit of $43.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-17
- IQVIA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $43.00M, a 19.44% increase from fiscal 2024.
- IQVIA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $36.00M, a 5.88% increase from fiscal 2023.
- IQVIA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $34.00M, a 21.43% increase from fiscal 2022.
- IQVIA HOLDINGS INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $28.00M, a 7.69% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|
| 2025-12-31 | $43.00M 10-K · filed 2026-02-17 | |
| 2024-12-31 | $36.00M 10-K · filed 2026-02-17 | |
| 2023-12-31 | $34.00M 10-K · filed 2026-02-17 | |
| 2022-12-31 | $28.00M 10-K · filed 2025-02-13 | |
| 2021-12-31 | $26.00M 10-K · filed 2024-02-15 | |
| 2020-12-31 | $14.00M 10-K · filed 2023-02-15 | |
| 2019-12-31 | $22.00M 10-K · filed 2022-02-16 | |
| 2018-12-31 | $19.00M 10-K · filed 2021-02-12 | |
| 2017-12-31 | $21.00M 10-K · filed 2019-02-19 | |
| 2016-12-31 | $21.00M 10-K · filed 2020-02-18 | $24.00M 10-K · filed 2017-02-16 |
| 2015-12-31 | $9.00M 10-K · filed 2018-02-16 | $8.90M 10-K · filed 2016-02-11 |
| 2014-12-31 | $8.00M 10-K · filed 2017-02-16 | $7.60M 10-K · filed 2015-02-12 |
| 2013-12-31 | $8.10M 10-K · filed 2016-02-11 | |
| 2012-12-31 | $6.90M 10-K · filed 2015-02-12 | |
| 2011-12-31 | $4.20M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |